Recent Tech Transfer Deals (09/2003)
This article was originally published in Start Up
Executive SummarySummarizing the month in tech transfer deals between Academia and Industry.
You may also be interested in...
Richard Pazdur, FDA's oncology chief, reiterates the breakthrough therapy designation is for agency-sponsor communication and not an investor tool.